|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsor: | University of Schleswig-Holstein |
|---|---|
| Information provided by: | University of Schleswig-Holstein |
| ClinicalTrials.gov Identifier: | NCT00638729 |
Purpose
alpha2-agonists like clonidine offer several useful effects that make these drugs an interesting alternative to benzodiazepines for pharmacological premedication. We therefore sought to determine the effect of pre-anesthetic medication with clonidine vs. midazolam in a randomized, double-blind, placebo controlled study. Effects of pre-anesthetic medication were assessed on (1) bispectral index (BIS),(2) sedation score and visual analog scales for anxiety and pain, (3) neuropsychologic tests to assess cognitive function and (4) circulating stress hormones.
| Condition | Intervention |
|---|---|
|
Anxiety Pain |
Drug: midazolam Drug: clonidine Drug: placebo |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Parallel Assignment Masking: Double Blind (Subject, Caregiver, Outcomes Assessor) Primary Purpose: Supportive Care |
| Official Title: | Effects of Clonidine and Midazolam Premedication on Bispectral Index and Recovery After Elective Surgery |
| Enrollment: | 60 |
| Study Start Date: | August 2005 |
| Study Completion Date: | March 2007 |
| Primary Completion Date: | March 2007 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: Midazolam
Pre-anesthetic medication with midazolam, 7.5 mg p.o., 60-90 min prior to estimated induction time
|
Drug: midazolam
midazolam, 7.5 mg p.o., 60-90 min prior to estimated induction time
Other Name: Dormicum
|
|
Active Comparator: Clonidine
pre-anesthetic medication with clonidine, 150 µg p.o., 60-90 min prior to estimated induction time
|
Drug: clonidine
pre-anesthetic medication with clonidine, 150 µg p.o., 60-90 min prior to estimated induction time
Other Name: Catapresan
|
|
Placebo Comparator: Placebo
Pre-anesthetic medication with an inert tablet, p.o., 60-90 min prior to estimated induction time
|
Drug: placebo
inert tablet p.o., 60-90 min prior to estimated induction time
|
Eligibility| Ages Eligible for Study: | 18 Years to 75 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| Germany | |
| Department of Anaesthesiology and Intensive Care Medicine, University of Schleswig-Holstein Campus Kiel | |
| Kiel, Germany, 24105 | |
| Study Chair: | Jens Scholz, M.D. | Chair of the Dept. of Anaesthesiology and Intensive Care Medicine, University of Schleswig-Holstein Campus Kiel |
More Information
| Responsible Party: | Prof. Dr. J. Scholz, Chair of the Department of Anaesthesiology and Intensive Care Medicine, University Schleswig-Holstein Campus Kiel |
| ClinicalTrials.gov Identifier: | NCT00638729 History of Changes |
| Other Study ID Numbers: | A 157/01, A 157/01 |
| Study First Received: | March 12, 2008 |
| Last Updated: | March 18, 2008 |
| Health Authority: | Germany: Federal Institute for Drugs and Medical Devices |
|
bispectral index sedation stress hormones cognitive function |
|
Anxiety Disorders Mental Disorders Anesthetics Midazolam Clonidine Central Nervous System Depressants Physiological Effects of Drugs Pharmacologic Actions Central Nervous System Agents Therapeutic Uses Antihypertensive Agents Cardiovascular Agents Sympatholytics Autonomic Agents Peripheral Nervous System Agents |
Adrenergic alpha-2 Receptor Agonists Adrenergic alpha-Agonists Adrenergic Agonists Adrenergic Agents Neurotransmitter Agents Molecular Mechanisms of Pharmacological Action Analgesics Sensory System Agents Adjuvants, Anesthesia Anti-Anxiety Agents Tranquilizing Agents Psychotropic Drugs Hypnotics and Sedatives Anesthetics, Intravenous Anesthetics, General |